Long term outcomes of transplantation using kidneys from expanded criteria donors: Prospective, population based cohort study

BMJ (Online)

Volumn 351, Issue , 2015, Pages

  Aubert, Olivier ^a   Kamar, Nassim ^b,c,d,e   Vernerey, Dewi ^a   Viglietti, Denis ^a,f   Martinez, Frank ^g   Duong Van huyen, Jean Paul ^a,g   Eladari, Dominique ^a,h   Empana, Jean Philippe ^a   Rabant, Marion ^g   Verine, Jerome ^f   Rostaing, Lionel ^b,c,d,e   Congy, Nicolas ^a,d,i   Guilbeau Frugier, Céline ^b,d   Mourad, Georges ^b,e   Garrigue, Valérie ^b,e   Morelon, Emmanuel ^e,j,k   Giral, Magali ^b,e,k   Kessler, Michèle ^b,e,k   Ladrière, Marc ^b,e,k   Delahousse, Michel ^a,l   Glotz, Denis ^a,e,f   Legendre, Christophe ^a,e,g,k   Jouven, Xavier ^a,h   Lefaucheur, Carmen ^a,e,f   Loupy, Alexandre ^a,e,g   more..

^a INSERM   (France)

^b Department of Nephrology and Organ Transplantation ^*  (France)

^c University of Toulouse III   (France)

^d UNIVERSITÉ PAUL SABATIER   (France)

^e DIVAT Données Informatiques VAlidées en Transplantation Network   (France)

^f SAINT LOUIS HOSPITAL   (France)

^g HÔPITAL NECKER ENFANTS MALADES   (France)

^h HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

ⁱ CHU RANGUEIL   (France)

^j EDOUARD HERRIOT HOSPITAL   (France)

^k Centaure Network   (France)

^l FOCH HOSPITAL   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; HLA ANTIBODY; HLA B ANTIGEN; HLA C ANTIGEN; HLA DP ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; ALLOANTIBODY; HLA ANTIGEN;

ADULT; AGE; ARTICLE; COHORT ANALYSIS; COLD ISCHEMIA; COMORBIDITY; DONOR SELECTION; EXPANDED CRITERIA DONOR; FEMALE; FOLLOW UP; FRANCE; GRAFT RECIPIENT; GRAFT SURVIVAL; HAZARD RATIO; HLA MATCHING; HUMAN; HUMAN TISSUE; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY DONOR; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; POPULATION RESEARCH; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RENAL GRAFT DYSFUNCTION; RISK ASSESSMENT; TREATMENT OUTCOME; ADOLESCENT; AGED; BLOOD; CHILD; CLINICAL TRIAL; IMMUNOLOGY; INFANT; KAPLAN MEIER METHOD; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; MULTICENTER STUDY; NEWBORN; PRESCHOOL CHILD; PROCEDURES; PROPORTIONAL HAZARDS MODEL; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COLD ISCHEMIA; DONOR SELECTION; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HLA ANTIGENS; HUMANS; INFANT; INFANT, NEWBORN; ISOANTIBODIES; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84941998299     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.h3557     Document Type: Article

References (36)

1. Réseau Epidémiologie et Information en Néphrologie. Annual report. 2013. www.socnephrologie.org/PDF/enephro/registres/rapport-2013/rapport-rein2013.pdf.
2. Evans RW, Manninen DL, Garrison LP Jr, et al. The quality of life of patients with end-stage renal disease. N Engl J Med 1985;312:553-9.
3. Port FK, Wolfe RA, Mauger EA, et al. Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients. JAMA 1993;270:1339-43.
4. Rana A, Gruessner A, Agopian VG, et al. Survival benefit of solid-organ transplant in the United States. JAMA Surg 2015;150:252-9.
5. Port FK, Bragg-Gresham JL, Metzger RA, et al. Donor characteristics associated with reduced graft survival: an approach to expanding the pool of kidney donors. Transplantation 2002;74:1281-6.
6. Eurotransplant. Annual report. 2013. https://www.eurotransplant.org/cms/mediaobject.php?file=AR20135.pdf.
7. L'Agence de la Biomédecine. Annual report. 2013. www.agencebiomedecine. fr/rapport-annuel-2013.
8. Organ Procurement and Transplantation Network/Scientific Registry of Transplant Recipients. Annual report. 2012. srtr.transplant.hrsa. gov/annual-reports/2012/pdf/2012-SRTR-ADR.pdf.
9. Sung RS, Christensen LL, Leichtman AB, et al. Determinants of discard of expanded criteria donor kidneys: impact of biopsy and machine perfusion. Am J Transplant 2008;8:783-92.
10. Cecka JM, Gritsch HA. Why are nearly half of expanded criteria donor (ECD) kidneys not transplanted? Am J Transplant 2008;8:735-6.
11. Tanriover B, Mohan S, Cohen DJ, et al. Kidneys at higher risk of discard: expanding the role of dual kidney transplantation. Am J Transplant 2014;14:404-15.
12. Metzger RA, Delmonico FL, Feng S, et al. Expanded criteria donors for kidney transplantation. Am J Transplant 2003;3 Suppl 4:114-25.
13. Merion RM, Ashby VB, Wolfe RA, et al. Deceased-donor characteristics and the survival benefit of kidney transplantation. JAMA 2005;294:2726-33.
14. Haas M, Sis B, Racusen LC, et al. Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibodyassociated arterial lesions. Am J Transplant 2014;14:272-83.
15. Sack K. In discarding of kidneys, system reveals its flaws. New York Times 2012 Sept 19.
16. Données Informatiques Validées en Transplantation (DIVAT) software. Homepage. www.divat.fr/.
17. Agence de la Biomédecine. Homepage. www.sipg.sante.fr/portail/.
18. Lefaucheur C, Loupy A, Hill GS, et al. Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation. J Am Soc Nephrol 2010;21:1398-406.
19. Lamb KE, Lodhi S, Meier-Kriesche HU. Long-term renal allograft survival in the United States: a critical reappraisal. Am J Transplant 2011;11:450-62.
20. Lee ET. Statistical methods for survival data analysis/2nd edition, John Wiley & Sons, 1992.
21. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing Risk. J Am Stat Assoc 1999;94:496-509.
22. D'Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998;17:2265-81.
23. Efron B. Bootstrap methods: another look at the jackknife. Ann Stats 1979;7:1-26.
24. Rao PS, Schaubel DE, Guidinger MK, et al. A comprehensive risk quantification score for deceased donor kidneys: the kidney donor risk index. Transplantation 2009;88:231-6.
25. Ojo AO, Hanson JA, Meier-Kriesche H, et al. Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates. J Am Soc Nephrol 2001;12:589-97.
26. Nankivell BJ, Alexander SI. Rejection of the kidney allograft. New Engl J Med 2010;363:1451-62.
27. Sellares J, de Freitas DG, Mengel M, et al. Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence. Am J Transplant 2012;12:388-99.
28. Nankivell BJ, Kuypers DR. Diagnosis and prevention of chronic kidney allograft loss. Lancet 2011;378:1428-37.
29. Gaston RS, Cecka JM, Kasiske BL, et al. Evidence for antibodymediated injury as a major determinant of late kidney allograft failure. Transplantation 2010;90:68-74.
30. Tuttle-Newhall JE, Krishnan SM, Levy MF, et al. Organ donation and utilization in the United States: 1998-2007. Am J Transplant 2009;9:879-93.
31. Frei U, Noeldeke J, Machold-Fabrizii V, et al. Prospective age-matching in elderly kidney transplant recipients-a 5-year analysis of the Eurotransplant Senior Program. Am J Transplant 2008;8:50-7.
32. Smits JM, Persijn GG, van Houwelingen HC, et al. Evaluation of the Eurotransplant Senior Program. The results of the first year. Am J Transplant 2002;2:664-70.
33. Lledo-Garcia E, Riera L, Passas J, et al. Spanish consensus document for acceptance and rejection of kidneys from expanded criteria donors. Clin Transplant 2014;28:1155-66.
34. Kayler LK, Srinivas TR, Schold JD. Influence of CIT-induced DGF on kidney transplant outcomes. Am J Transplant 2011;11:2657-64.
35. Debout A, Foucher Y, Trebern-Launay K, et al. Each additional hour of cold ischemia time significantly increases the risk of graft failure and mortality following renal transplantation. Kidney Int 2015;87:343-9.
36. Azancot MA, Moreso F, Salcedo M, et al. The reproducibility and predictive value on outcome of renal biopsies from expanded criteria donors. Kidney Int 2014;85:1161-8